Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-03-05 @ 1:55 AM
Study NCT ID:
NCT02835534
Status:
COMPLETED
Last Update Posted:
2022-05-25
First Post:
2016-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
Sponsor:
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-12
First Submit QC Date:
None
Study First Post Date:
2016-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-19
Last Update Post Date:
2022-05-25
Last Update Post Date Type:
ACTUAL